CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.

Verapamil-Darnitsa

Release forms:
Paroxysmal supraventricular tachycardia, atrial flutter/fibrillation (not including Wolff–Parkinson–White syndrome (WPW)). Unstable angina in patients for whom nitrates and/or β˗blockers are contraindicated, including vasospastic angina, Prinzmetal's variant angina. Arterial hypertension; hypertensive crisis. In children: in paroxysmal supraventricular tachycardia.
Characteristics of the productу:
    • Release formInjectable solution
    • ChildrenWith caution
    • PregnantWith caution
    • NursingWith caution
    • Release categoryPrescription medication
    • With alcoholWith caution
    • DriversWith caution
    • Temperature storage conditionsNot higher than 25 °С
    • Qualitative and quantitative composition:
    • Pharmaceutical form.
    • Clinical particulars.
    • Children
    • Overdose.
    • Packaging.
    • Category of release
    • Manufacturer.
    • The manufacturer's location and address of the place of business.
    • Date of last revision.